Enhancement of Hepatitis E Virus Dna Vaccine Immunity by Beclin-1-Mediated Autophagy Publisher



Naziri H¹ ; Abdoli A² ; Ghaemi A³ ; Motevalli F² ; Owlia P⁴ ; Ghanei M⁵ ; Bahramali G² ; Salimi V¹ ; Aghasadeghi MR² ; Yavarian J¹ Show Affiliations
Source: Jundishapur Journal of Microbiology Published:2017

Abstract

Background: The Hepatitis E virus (HEV) infection is a serious public health problem, with a mortality rate of approximately 20- 25% among pregnant women. DNA vaccination was reported to induce humoral and cellular immune responses in murine models; however, a major problem of the strategy is its limited potency. Methods: In this study, we have investigated whether Beclin1, as an autophagy-inducing based plasmid, can serve as an immunostimulatory agent and promote the HEV specific protective immunity of naked DNA vaccine encoding truncated ORF-2 (HEV239). Plasmids encoding HEV239 with or without Beclin1 were used for the BALB/c mice immunization. Results: The results demonstrated a significant increase microtubule-associated protein light chain-3 II (LC3 II) as a marker of autophagy in the HEK293 cell, which were transfected by pVITRO-Beclin1 plasmid. The immunological effects of adding Beclin1 to HEV239 ORF-2 DNA vaccines were associated with the induction of the antigen-specific lymphocyte proliferation and the Th1-type cytokine (gamma-interferon (IFN-γ)), while there were no differences in IL-4 levels between the groups. Examination of humoral immune responses in vaccinated mice represented that immunization with pVITRO-HEV239- Beclin1 notably increased serum level of IgG2a and total IgG against HEV in comparison to the HEV239 plasmid alone. Conclusions: The strong Th1 immune response induced by the Beclin1 suggest that induction of autophagy can be an efficient approach to enhance the immunogenicity of DNA vaccine. This promising procedure could be further exploited as a potential therapeutic vaccine candidate in future studies. © 2017, Jundishapur Journal of Microbiology.